Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Scientists at UCSF have built the largest-ever molecular interaction map for autism, revealing how hundreds of different genetic mutations funnel into a surprisingly small number of shared protein networks. Published in Science, the landmark study suggests that drugs targeting these common molecular hubs could treat multiple genetic forms of autism at once — no need for a different therapy for every mutation.
For decades, researchers knew that hundreds of genes could raise the risk of autism spectrum disorder (ASD), but connecting those genes to actual brain changes — and to treatments — remained elusive. A new UCSF study published in Science changes that. Scientists mapped protein-protein interactions for 100 high-confidence autism risk genes, creating the most detailed molecular diagram of autism ever assembled. The big surprise: despite autism's enormous genetic diversity, the disease-causing mutations tend to disrupt the same small set of shared protein complexes.
That convergence is a game-changer for drug development. Rather than needing a bespoke therapy for every mutation, researchers could target these common molecular hubs to treat many genetic forms of autism simultaneously. The team also uncovered a new disease mechanism — some mutations don't just break a gene, they trigger a harmful gain of function in a partner protein, opening entirely new therapeutic avenues.
By the Numbers:
Why it matters: This study doesn't just advance autism research — it offers a replicable blueprint for translating the genetics of almost any complex disease into a targeted treatment strategy, from neurodegeneration to cancer.
